Pulmonx
Adrien Jousset is a seasoned professional with extensive experience in territory management and medical device promotion. Currently serving as Territory Manager for Pulmonx Corporation since April 2023, Jousset previously held roles at Asept InMed from May 2018 to March 2023, specializing in urological intervention and enteral nutrition as a Délégué Hospitalier. Responsibilities included revenue management, product launches, user training, and competitive analysis. Jousset's career began at Chronopost, where from February 2009 to May 2018 as Chargé d'Affaires, responsibilities encompassed client portfolio management and service promotion in the Moselle/Luxembourg region. Jousset holds a DUT in Techniques de Commercialisation from IUT de Caen.
This person is not in any offices
Pulmonx
2 followers
Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1